Correction to: Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis
| Autor: | Jean-Luc Fellahi, Felix A. Achana, Enrique Guilherme, Matthias Jacquet-Lagrèze, Xavier Armoiry, Matteo Pozzi |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
ECMO weaning failure
Adult Male medicine.medical_specialty Cardiotonic Agents Levosimendan Shock Cardiogenic MEDLINE 030204 cardiovascular system & hematology Critical Care and Intensive Care Medicine Cohort Studies 03 medical and health sciences Extracorporeal Membrane Oxygenation 0302 clinical medicine VA-ECMO medicine Humans Propensity Score Cardiogenic shock Simendan Aged business.industry Research Circulatory failure lcsh:Medical emergencies. Critical care. Intensive care. First aid Correction lcsh:RC86-88.9 Middle Aged medicine.disease 3. Good health surgical procedures operative 030228 respiratory system Propensity score matching Emergency medicine Weaning failure Female France business Ventilator Weaning medicine.drug Cohort study |
| Zdroj: | Critical Care Critical Care, Vol 24, Iss 1, Pp 1-3 (2020) |
| ISSN: | 1364-8535 |
| DOI: | 10.1186/s13054-020-03213-w |
| Popis: | Background Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has been increasingly used over the last decade in patients with refractory cardiogenic shock. ECMO weaning can, however, be challenging and lead to circulatory failure and death. Recent data suggest a potential benefit of levosimendan for ECMO weaning. We sought to further investigate whether the use of levosimendan could decrease the rate of ECMO weaning failure in adult patients with refractory cardiogenic shock. Methods We performed an observational single-center cohort study. All patients undergoing VA-ECMO from January 2012 to December 2018 were eligible and divided into two groups: group levosimendan and group control (without levosimendan). The primary endpoint was VA-ECMO weaning failure defined as death during VA-ECMO treatment or within 24 h after VA-ECMO removal. Secondary outcomes were mortality at day 28 and at 6 months. The two groups were compared after propensity score matching. P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink